Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

422.32 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 20, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

68 69 Next >

What Analysts Are Saying About Vertex Pharmaceuticals Stock ↗

October 01, 2024

Via Benzinga

Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit. ↗

September 26, 2024

Pfizer stock dipped Thursday after the company voluntarily pulled its sickle cell drug, Oxbryta, from the market following patient deaths.

Via Investor's Business Daily

Vertex Highlights First Oral Presentation of Phase 3 Clinical Data of the Vanza Triple and New Data on Long-Term Impact of TRIKAFTA® at the North American Cystic Fibrosis Conference

September 26, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,200 Today ↗

September 25, 2024

Via Benzinga

Demystifying Vertex Pharmaceuticals: Insights From 16 Analyst Reviews ↗

September 19, 2024

Via Benzinga

Looking Into Vertex Pharmaceuticals's Recent Short Interest ↗

September 18, 2024

Via Benzinga

Vertex Pharmaceuticals's Options Frenzy: What You Need to Know ↗

August 29, 2024

Via Benzinga

The Best Biotech Stock to Invest $1,000 in Right Now ↗

September 22, 2024

Vertex Pharmaceuticals isn't an ordinary biotech stock.

Via The Motley Fool

Bull Market and Beyond: 2 Stocks Just Waiting to Soar ↗

September 21, 2024

Great companies have persisted even in a tumultuous market.

Via The Motley Fool

Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 ↗

September 18, 2024

These biotech stocks have what it takes to be the biggest winners through the rest of the decade and beyond.

Via The Motley Fool

3 Stocks to Buy and Hold Forever ↗

September 14, 2024

These stocks are built for the long run.

Via The Motley Fool

Prediction: These 3 Phenomenal Stocks Are Set to Soar ↗

September 14, 2024

These stocks are already solid winners in 2024. They should be able to keep the momentum going.

Via The Motley Fool

Time To Invest And Or Trade In Bio-Tech Stocks? ↗

September 13, 2024

Biotechnology stocks and biotech exchange-traded funds ETFs once played a significant role in growth equity rallies, but today it seems like those days are in the past. Will an interest rate cut help...

Via Talk Markets

Topics ETFs

Looking Into Vertex Pharmaceuticals's Recent Short Interest ↗

August 27, 2024

Via Benzinga

Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals ↗

August 23, 2024

Via Benzinga

Biotech Breakout: Stocks for Your Watchlist

September 12, 2024

The iShares Biotechnology ETF (IBB) has turned $140 resistance into support, positioning the overall sector for a potential breakout above $150.

Via MarketBeat

Topics ETFs

Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years ↗

September 06, 2024

Via Benzinga

3 No-Brainer Stocks to Buy in September ↗

August 31, 2024

There's at least one key common denominator here: tremendous growth prospects.

Via The Motley Fool

3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever ↗

August 30, 2024

These three have secure core businesses, plus multiple paths to grow.

Via The Motley Fool

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow ↗

August 30, 2024

Vertex should have a future full of bright tomorrows.

Via The Motley Fool

If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,900 Today ↗

August 21, 2024

Via Benzinga

Biotech And Life Science Sector Update Summer Of 2024 ↗

August 29, 2024

It’s the slowest week of the year, we are at the market top and most earnings reports are good.

Via Talk Markets

Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics ↗

August 29, 2024

Jim Cramer discusses Serve Robotics, Builders FirstSource, Vertex Pharmaceuticals and Viking Therapeutics on CNBC.

Via Benzinga

Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead ↗

August 23, 2024

Vertex Pharmaceuticals has a lot going for it.

Via The Motley Fool

Vertex to Participate in Upcoming September Investor Conferences

August 22, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Biotech Bull Market: 3 Ways To Play It ↗

August 20, 2024

Although we are in the later stages of this bull market a cut in interest rates by the Fed should help biotech as you have seen from the recent rally.

Via Talk Markets

Topics Economy

Soviet Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings ↗

August 19, 2024

Renaissance Technologies, the hedge fund founded by legendary mathematician and former NSA code breaker Jim Simons, recently disclosed its latest stock holdings in a 13F filing with the U.S. Securities...

Via Benzinga

These 2 Incredible Growth Stocks Are Set to Soar This Summer and Beyond ↗

August 18, 2024

It's always a good time to invest cash in quality businesses.

Via The Motley Fool

3 Fantastic Growth Stocks to Buy in August ↗

August 17, 2024

These stocks should keep up their winning ways.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 15, 2024

Via Benzinga

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

68 69 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.